# ChatGPT and cancer

## Large language models and AI agents in oncology - a primer

Jakob Kather (Dresden, Germany)

AI-results not validated

## Lessons learned from implementing LLMs in a cancer centre

Mihaela Aldea (Villejuif, France)

10 000 LC patients

Opt-out process, 0,3% opted out! Number went down by refining the information more spatient-friendly (with chapGPT!)

Prospective LLM trial on cancer ongoing in France

## Large language models for drug development and cancer therapy

Loic Verlingue (Lyon, France)

Target prediction - LLM preprint

Structure prediction - Alphafold

AI-powered drug development



## Agentic AI in oncology

Daniel Truhn (Aachen, Germany)



## QA

trial matching: LLM does not have access to everything the doctor has access to - an unfair setting



